| Miss Kahkashan Neseem, BS | |
|
3800 Fairfax Dr, Appartment#306, Arlington, VA 22203-1711 | |
| (703) 243-9343 | |
| Not Available |
| Full Name | Miss Kahkashan Neseem |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 3800 Fairfax Dr, Arlington, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457487142 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Kahkashan Neseem, BS 3800 Fairfax Dr, Appartment#306, Arlington, VA 22203-1711 Ph: (703) 243-9343 | Miss Kahkashan Neseem, BS 3800 Fairfax Dr, Appartment#306, Arlington, VA 22203-1711 Ph: (703) 243-9343 |
News Archive
The EHEC crisis in Germany in 2011 proved that food brought in from other countries can potentially carry agents that cause life-threatening diseases. Nevertheless, there have been extremely few investigations of the actual danger posed by germs that enter the EU along with food. The gap is now to be addressed by a new project, with the EU providing almost three million Euro to cover the costs.
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented Protalix (NYSE-Amex: PLX), a leading biopharmaceutical company, in its licensing agreement with Pfizer Inc. to develop and commercialize a potential treatment for Gaucher's disease, a genetic disorder.
Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient's treatment and enable physicians to provide a more accurate prognosis.
› Verified 7 days ago
Sarah N Peters, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2110 Washington Blvd, Arlington, VA 22204 Phone: 703-228-6065 | |
Katherine Elise Lloyd, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 900 N Taylor St, Arlington, VA 22203 Phone: 832-518-9633 | |
Alyssa Barker, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4620 Cherry Hill Rd Ste 215, Arlington, VA 22207 Phone: 703-243-4600 | |
Mrs. Hilary Dwyer Ananka Dilks, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3712 N Albemarle St, Arlington, VA 22207 Phone: 703-786-6888 | |
Marit Simenson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5950 8th Rd N, Arlington, VA 22205 Phone: 703-228-5270 | |
Tyler A Trzcinski, MSOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4620 Cherry Hill Rd Ste 215, Arlington, VA 22207 Phone: 703-243-4600 | |
Fiona D'souza Kumar, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1785 S Hayes St, Arlington, VA 22202 Phone: 703-685-3072 |